[18F]Flutemetamol

DRUG4 trials

Sponsors

GE Healthcare, University of Utah

Conditions

Alzheimer's DiseaseBreast CancerDementiaMild Cognitive ImpairmentNormal Pressure Hydrocephalus

Phase 2

Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment

TerminatedNCT02317783

University of UtahBreast Cancer

Start: 2018-01-31End: 2019-09-24Updated: 2024-11-20

Phase 3

Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydrocephalus

TerminatedNCT01092546

GE HealthcareNormal Pressure Hydrocephalus

Start: 2010-03-31End: 2011-04-30Updated: 2013-12-13

Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) Images

CompletedNCT01672827

GE HealthcareAlzheimer's Disease, Mild Cognitive Impairment

Start: 2012-07-31End: 2012-08-31Updated: 2014-01-24

Unknown Phase

Implications for Management of PET Amyloid Classification Technology

CompletedNCT02778971

University of UtahAlzheimer's Disease, Dementia, Mild Cognitive Impairment

Start: 2016-06-30End: 2022-09-30Updated: 2023-04-24

Related Papers

Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection.

2016-12-1283 citations